Tumour suppressor genes |
Chromosomal instability |
APC |
85 |
Somatic mutations inactivating both copies of APC are present in most sporadic colorectal cancers; A germ-line mutation in familial adenomatous polyposis with an 80% to 100% lifetime risk of colorectal cancer. Activation of Wnt signaling due to inability to degrade the β-catenin oncoprotein [27,28,29,30,31]. |
PTEN |
10–15 |
Germ-line mutations that promote activation of PI3K pathway signaling through loss of function [32,33,34]. |
TP53 |
35–55 |
Germ-line mutation in Li-Fraumeni syndrome; inactivates missense mutations pairs with loss of heterozygosity at 17p [35,36,37]. |
SMAD4 |
10–35 |
Germ-line mutation in approximately 40% of juvenile polyposis; a critical component of transforming growth factor β signaling pathway; inactivated by homozygous or mutation with loss of heterozygosity at 18q [38,39,40,41]. |
DNA mismatch-repair defects |
MLH1, MSH2, MSH6 MYH
|
15–25 |
Germ-line mutation permitting the accumulation of oncogenic mutations and tumour suppressor loss [42,43,44]. |
Aberrant DNA methylation |
MLH1 |
15 |
Silencing of the promoter region of the genes in mismatch-repair system by hyper-methylation of CpG islands [45,46]. |
Oncogenes |
DNA mismatch-repair defects |
RAS, BRAF
|
13–37 |
Activates the mitogen-activated protein kinase signaling pathway [47,48,49]. |